Dual-trigger hyaluronic acid nanoprodrug incorporating a 2-nitrobenzenesulfonyl linker for CD44-targeted and glutathione-responsive drug delivery
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Proteoglycans and glycosaminoglycans research
Publication details
- Journal / source
- International Journal of Pharmaceutics
- Publisher
- Elsevier BV
- Volume
- 701
- Pages
- 127157–127157
- Publication date
- 4 July 2026
- Language
- EN